PEARW - Pear Therapeutics Inc. (PEAR) CEO Corey McCann on Q1 2022 Results - Earnings Call Transcript
Pear Therapeutics, Inc. (PEAR) Q1 2022 Earnings Conference Call May 16, 2022 4:30 PM ET Company Participants Meara Murphy - Senior Director of Corporate Communications Ronan O'Brien - General Counsel and Chief Compliance Officer Corey McCann - President and Chief Executive Officer Chris Guiffre - Chief Financial Officer and Chief Operating Officer Yuri Maricich - Chief Medical Officer Julia Strandberg - Chief Commercial Officer Conference Call Participants Michael Cherny - Bank of America Charles Rhyee - Cowen Neena Bitritto-Garg - Citi Eric Percher - Nephron Research Keay Nakae - Chardan Judah Frommer - Credit Suisse Marie Thibault - BTIG Presentation Operator Good afternoon, everyone. Welcome to the Pear Therapeutics First Quarter 2022 Earnings Conference Call. My name is Justin, and I'll be your operator today. All lines have been placed on mute to prevent background noise. This call is being recorded. A replay of the webcast will be available in
For further details see:
Pear Therapeutics, Inc. (PEAR) CEO Corey McCann on Q1 2022 Results - Earnings Call Transcript